All Roll Calls
Yes: 261 • No: 41
TexasSB 67089th Legislature Regular SessionSenateWALLET
Relating to patient authorization to access certain investigational sun protection products.
Sponsored By: Elizabeth "Liz" Campos, Bryan Hughes (Republican)
Became Law
Health Care ProvidersHealth--GeneralINFORMED CONSENTPATIENT RIGHTS & PROTECTIONPHYSICIANSMEDICAL BOARD, TEXAS
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
4 provisions identified: 1 benefits, 1 costs, 2 mixed.
Doctors gain protection for experimental prescriptions
The Texas Medical Board cannot discipline a doctor's license solely for recommending or prescribing experimental sun protection to an eligible patient. This includes revoking, suspending, or refusing to renew the license. The recommendation or prescription must meet the medical standard of care and this law's requirements.
No new claims for product harm
This law creates no new private or state legal claim for harm caused by using the experimental sun protection product. This applies to claims against manufacturers and others involved in an eligible patient's care. It does not say that all other possible legal claims are barred.
Patients gain access to experimental sun protection
Texas allows access to sun protection containing an ingredient that completed Phase I testing, remains under study, and lacks general FDA approval. After consulting you, your doctor must find all FDA-approved sun protection products less effective and recommend or prescribe it in writing. Beforehand, you must sign informed consent; a parent or legal guardian may consent for minors or patients lacking mental capacity. Texas officials, employees, and agents cannot block or try to block eligible patients' access. The act sets immediate effect with a two-thirds vote in each chamber; otherwise, the effective date is September 1, 2025.
Patients may pay experimental product costs
Manufacturers may supply experimental sun protection to eligible patients who provide the required informed consent, following the law and its rules. They do not have to supply it. They may offer it free or charge their manufacturing or related costs. The law leaves existing health coverage rules for clinical trial enrollees unchanged.
Sponsors & Cosponsors
Sponsors
Elizabeth "Liz" Campos
House
Bryan Hughes
Republican • Senate
Cosponsors
There are no cosponsors for this bill.
Roll Call Votes
House vote • 5/21/2025
Record vote
Yes: 115 • No: 27
House vote • 5/20/2025
Record vote
Yes: 126 • No: 14
Senate vote • 4/10/2025
Record vote
Yes: 0 • No: 0
Senate vote • 4/10/2025
Record vote
Yes: 0 • No: 0
House vote • Unknown
Committee vote: Public Health
Yes: 12 • No: 0
Senate vote • Unknown
Committee vote: Health & Human Services
Yes: 8 • No: 0
Bill Text
Engrossed
Enrolled
House Committee Report
Introduced
Senate Committee Report
Related Bills
SB 650, Relating to requiring the use of electronically readable information to verify a purchaser's age in the retail sale of alcoholic beverages.
SB 646, Relating to repayment of certain mental health professional education loans.
SB 25, Relating to health and nutrition standards to promote healthy living, including requirements for food labeling, primary and secondary education, higher education, and continuing education for certain health care professionals; authorizing a civil penalty.
HB 4325, Relating to civil liability for prohibited barratry.
HB 4042, Relating to the applicability of certain safety provisions and regulatory fees administered by the Railroad Commission of Texas to gas distribution pipelines.
HB 3372, Relating to prohibiting certain personal services performed by school district administrators; providing a civil penalty.